Fenoterol increases erythropoietin concentrations during tocolysis

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • C. H. Gleiter - , Georg-August-Universität Göttingen (Autor:in)
  • K. H. Schreeb - , Georg-August-Universität Göttingen (Autor:in)
  • S. Goldbach - , Georg-August-Universität Göttingen (Autor:in)
  • S. Herzog - , Georg-August-Universität Göttingen (Autor:in)
  • T. Cunze - , Georg-August-Universität Göttingen (Autor:in)
  • W. Kuhn - , Georg-August-Universität Göttingen (Autor:in)

Abstract

Aims. The present study was carried out to assess the effect of the selective β2-adrenoceptor agonists on erythropoietin (EPO) production. Methods. Routine tocolysis with fenoterol (using the regular rate of 2 μg min-1) was used as a clinically easily accessible model. Results. EPO concentrations had doubled 24 h after the start of tocolysis (P < 0.001). This increase lasted over the entire observation period of 48 h. Potassium concentrations fell significantly during the first hours of fenoterol infusion. There was no increase of human placenta lactogen during the period of EPO increase. Conclusions. The data confirm our earlier results that fenoterol increases EPO concentrations following haemorrhage. In this model it was not necessary to stimulate EPO production prior to pharmacological treatment.

Details

OriginalspracheEnglisch
Seiten (von - bis)157-159
Seitenumfang3
FachzeitschriftBritish journal of clinical pharmacology: BJCP
Jahrgang45
Ausgabenummer2
PublikationsstatusVeröffentlicht - Feb. 1998
Peer-Review-StatusJa
Extern publiziertJa

Externe IDs

PubMed 9491829

Schlagworte

Schlagwörter

  • Erythropoietin, Fenoterol, Human placenta lactogen, Metoprolol, Pregnancy, Tocolysis